We would like to show you a description here but the site won’t allow us.

Certain applications of Luminex products, may be covered by patents owned by parties other than Luminex. Purchase of Luminex products does not convey a license to any third party patents unless explicitly stated in writing.

Luminex Corporation develops, manufactures & markets biological testing technologies in the clinical diagnostic and life science industries.

Terms of Use Disclaimer Privacy Policy© 2021 Luminex Corporation. A DiaSorin Company. All rights reserved.

AUSTIN, Texas, Jan. 12, 2021 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced 4 th quarter 2020 revenue of approximately $111M, up approximately 23% over the 4 th quarter of 2019 and full-year revenue of approximately $417M, up …

The Luminex portfolio for gastrointestinal diagnostics includes the ARIES® C. difficile Assay, the VERIGENE® Enteric Pathogens Test (EP), and the xTAG® Gastrointestinal Pathogen Panel (GPP), which offers the ability to mask targets and create custom panels for patient populations.

Luminex developed the original ARIES ® SARS-CoV-2 Assay with financial support from BARDA earlier this year. Since the COVID-19 pandemic began, Luminex has expanded capacity for SARS-CoV-2 testing across its diagnostic platforms.

ausagileprod.luminexcorp.com:7001

He joined Luminex in October 2012 as General Manager, Americas. Prior to Luminex, he held roles as VP of Sales and VP of Commercial Operations at Immucor, Inc., where he was responsible for Commercial Operations (Sales, Marketing, Customer Service functions).

SDS, Verigene BC-GP Utility Kit, French (Switzerland) - Luminex Corporation ... VDOM